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Previous  studies  (1-3)  have  demonstrated  that  staphylococcal  coagulase  is 
antigenic.  During  the  course  of  these  investigations  it  was  observed  that  the 
anticoagulase  titer  of  human  sera  varied  considerably  and  could  not  always 
be correlated with a past history of staphylococcal infections. It seemed possible 
that  staphylococcal  coagulases  might  differ  antigenically.  The  present  paper 
reports  observations  concerning  the antigenic  relationships  of several cell-free 
preparations  of coagulase. 
Methods 
Coagulase.--Cell-free coagulase was prepared from a number of coagulase-positive strains 
of Staphylococcus aureus. The 3 coagulases  which were finally selected for intensive study were 
prepared from strains 17, 142, and 58, and were termed coagulases  I, II, and III, respectively. 
Strain  17  was isolated from an infected cyst in  1946 by Dr. Robert F.  Parker.  Strain  142 
was isolated from the sputum  of a  patient with pneomonia, and  strain  58 from the throat 
swab of a normal male. 
The three preparations of coagulase were prepared by growing each of the strains in tryptose 
broth containing 5 per cent bovine albumin.  1 From 5  to 10 ml. of an overnight culture of 
S. aureus was inoculated into 500 ml. of broth containing albumin. Mter incubation at 37°C. 
for 3 days, the cells were separated by centrffugation. The supernatant was then passed through 
a  Seitz filter and  the filtrate tested for sterility. The filtrate was then stored either at  --4  ° 
or at 4°C. in small flasks or sealed ampules. The coagulase in each preparation was measured 
by a technique already described (4). 
In a few instances animals were injected with coagulase prepared by growing the organism 
in broth containing 5 per cent human plasma rather than albumin. The amount of coagulase 
in such preparations cannot be quantitated because of the presence of a variable amount of 
reacting factor in the plasma used in the culture medium (4). 
Anticoagulase Determinations.--The  method  used  to  measure  the  anticoagulase  titer  of 
human and animal sera has been published (4). In each instance all sera from a single animal 
were titrated in the same test. The titers are expressed  as the reciprocal of the initial dilution 
of serum. 
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RESULTS 
Obserr~ions  of Human S~m.-- 
The antibody titer of 148 specimens of serum obtained from medical students was measured 
with the 3 antigens, each of which had been carefully standardized several times. A group of 
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Titers are expressed as units of anticoagulase in the initial dilution of serum. If the 2 anti- 
gens were measuring the same inhibitor, all titers should fall within the diagonal lines which 
delineate the magnitude of technical error involved in the test. 
30 to 40 sera was tested against all antigens each day the test was performed. The results 
are tabulated in Tables I, II, and III. 
The anticoagulase titer was less than 11 in 27, 89, and 81 specimens of serum when tested 
with coagulases I, II, and III, respectively. These data suggest that coagulase I  may be un- 
related to coagulases II and III. Inspection of Table III indicates that coagulases II and III 
may not be related since 29 of the 89 sera which had titers of less than 11 when tested with 
coagulase II, showed titers of 17 or greater when tested with coagulase III. DMMELKAMP~  HEZEBICKS~  AND  DINGLE  297 
Certain  sera,  especially those  exhibiting  a  high  anticoagulase  titer  when 
tested with preparation  I,  exhibited a  high titer to more than one antigen. 
This result suggests either that these antigens were related or that individuals 
whose sera show high anticoagulase titers are also likely to possess antibodies 
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See Table I. 
to other coaguIase preparations. That the antigens are not necessarily related 
is suggested by the fact that sera showing a high titer to one antigen may con- 
tain no detectable antibody to a second antigen. There were 5 specimens with a 
titer of anticoagulase of 900 when tested with coagulase I  (Tables I  and I-I); 
one of these showed no antibody against coagulase III, and 2 showed titers of 
< !l when tested with preparation II. 
The above results indicate that coagulases from different strains of staphy- 298  SPECIFIC COAGD'LASES OP  STAPHYLOCOCCUS AIYREUS 
loe0cci  may vary  antigenically,  although  the  existence  of  certain  cross-reactions 
could not  be  eliminated. 
That these  results  are not due to technical  error  is  shown by the data pre- 
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sented  in  Table  IV.  Forty-four  serum  specimens  were  examined  using  as 
antigens  two separate coagulase lots prepared from strain I. These two lots 
were prepared  at  different  times  and  differed  in  their  coagulase  activities. 
The antibody titers of all sera fell within the 1Lrnits of technical error. Thirty 
of the 44 were found to have the same anticoagulase titer with the 2 antigens; 
the remainder of the sera showed only a one dilution variation in titer. RA~ELKAMP~ HEZEBICES~ AND DINGLE  299 
Immunization Experiments.- 
Monkeys were inoculated with cell-free coagulase, and the anficeagulase titers to the 3 
antigens were determined in one test. The results of one such study are shown in Fig. 1. This 
monkey received 3 series of injections of coagulase III during a  period of 33 days, a  total of 
TABLE  IV 
Antibody  Tilers  of 44 Sera  to  Two  Different Preparations  of Coagulase I 
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2,565 units being injected intramuscularly. The specific response to the homologous antigen 
was well demonstrated; there was no change in the anticoagulase titers measured by antigens 
I  and II. On the 107th day after immunization, antigen I  was used in a  series of injections 
totaling only 175 units. The anticoagulase titer, when measured with coagulase I, increased 
to 56; there was a  one dilution increment increase in anticoagulase III, and no change in the 
titer against the II antigen. Finally, on the 277th day antigen II was injected. Here a total of 
675 units was used. There was only a small response to the homologous antigen in this instance, 300  SP~-CI~IC COAGULASES O]~  STAPHYLOCOCCUS AUREUS 
a 2-tube increase  in anticoagulase Ill,  and no change in titer  of anticoagulase when measured 
with antigen I. 
The differences  in the antibody response to the 3 antigens can be explained 
by the different  amounts of antigens  used.  This experiment suggests  that the 3 
antigens are different,  but antigens I and II may be related  to antigen III, 
since  administration of the former 2 antigens resulted  in a slight  rise  in anti- 
bodies when tested  with coagulase  III. 
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FIG. 1.  Immune response of monkey to coagulases  I, II, and III. 
A  second  monkey was inoculated with 0.5  ml.  of an  overnight culture  of S.  aureu~  of 
coagulase type I and 3.0 ml. of strain 55, ~ the antigenic composition of which was not known 
(Fig.  2).  Boils did not develop and  the only evidence of infection was slight redness and 
induration appearing 48 hours after the injection. There was no change in the anticoagulase 
titers  following this  apparently  mild infection.  On  the 46th  day  after  the inoculation  of 
staphylococci a  series  of  cell-free coagulase  injections  was  instituted,  using  coagulase  II 
prepared from strain  142 grown in plasma. The total number of units injected could not be 
measured, hut the preparation clotted fibrinogen after 3 hours' incubation in an initial dilution 
of 1:55, indicating moderate activity. There was no change in the antibody titers measured 
with the 3 antigens. 
Finally the monkey received 10 injections of 2 ml. each of an overnight culture of organisms 
Staphylococcus strain  55 was used in this  and subsequent experiments in a study of the 
immune mechanisms, the results  of which will  be reported in a subsequent communication. RAMMELKAM~P~ HEZEBICKS~  AND  DINGLE  301 
which  produced  coagniase  I.  Boils,  which  subsequently drained,  were  produced  by  each 
series of injections of S. aureus. There was an immediate increase in anticoagnlase measured 
with type I antigen, but the anticoaguiase titers to types II and III coagulases did not change. 
These experiments in this monkey are significant not only because they show a specific response 
to  the  homologous  coagnlase,  but  because  anticoagnlase  developed  following an  induced 
infection. 
The final immunization experiment to be presented in detail is shown in Fig. 3. This animal 
was first inoculated with cell-free coagulase I  prepared in broth containing plasma.  It was 
active in an initial dilution of 1:25 as determined by 3 hours' incubation at 37°C.  A total of 
36 ml. was administered in 18 injections. There was an immediate elevation of anticoagnlase 
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FIG. 2.  Specific anticoagnlase response following injection with a coagulase I strain. 
* Number of units unknown, since the coagniase preparation contained reacting factor. 
when measured by antigen I, but no increase, other than a slight rise on the 42nd day, to the 
II and III antigens. 
On the 73rd day the animal was injected with an overnight culture of S. aureus of coagulase 
type I  and strain 55; 0.5 ml. and 3.0 ml.  respectively being administered intramuscularly. 
These injections resulted in the production of a large boil and an increase in the anticoagnlase 
titer of the convalescent serum when tested with the type III antigen. The anticoagnlase titer 
to coagulase  I,  which  had  been  falling,  remained  at  a  constant  level  for  45  days.  It  is 
possible that the rise in the anticoagniase titer against type III antigen may be due to the 
presence of a  similar antigen in strain 55, or it may be related to the infection produced by 
the organisms of coagulase type I. 
Cell-free type II coagulase made in plasma broth was now administered. Ten injections of 
3 ml. each were given. The preparation clotted fibrinogen in an initial dilution of 1:55. An 
immediate increase in titer to coagulase II resulted, as well as an increase of anticoagulase 
to the III antigen, and to a  lesser extent to I antigen. 
A total of 240 units of cell-free coagulase type I was given in a second series of injections. 302  SPECIFIC  COAGULASES  0]~  STAPHYLOCOCCUS  AITREUS 
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Again there was an increase in the homologous antibodies, and a slight increase in antibodies 
to coagulases  II and III. Finally, the animal received  15 more injections of coagulase  II, a 
total of 1,675 additional units. There was a response in the anticoagulase titer of the homol- 
ogous type, and to a lesser extent in that of type III. The titers of antibody to the 3 antigens 
then declined at different rates. 
Monkeys were injected with 6 preparations of cell-free coagulase  derived from different 
strains of staphylococci.  Among these, coagulases  I, II, and III appeared to be most distinct 
antigenically. Few cross-reactions  were  observed between coagulases  I  and II, and in each 
instance they were of minor degree and may represent an anamnestic reaction. In contrast, 
coagulase  II appeared to stimulate antibodies of the III type (Fig. 3), and in other studies 
not reported here, the injection of coagulase  I  was followed by an increase in the titer of 
antibodies to coagulase III. 
The  results  indicate  that  coagulases  vary  antigenically  although  certain 
cross-reactions occur. It seems probable, therefore, that the differences noted 
with human sera tested with coagulase from different strains of staphylococci 
can be explained on this basis. 
Neutralization Experiments 
The  immunization experiments  demonstrated  that  monkeys responded  by 
antibody formation to  the homologous antigen. If the coagulase preparations 
employed were truly distinct, it should be possible to remove or to neutralize one 
antibody without affecting appreciably the  concentration of the heterologous 
antibody. Furthermore,  possible cross-reactions between the coagulase prepa- 
rations might become more apparent by employing such techniques. 
Three  procedures  were  used  in  these  experiments:  The  serum  was  mixed 
with  staphylococcal  cells,  with  collodion  particles  coated  with  coagulase,  or 
with cell-free coagulase. 
Neutralization  with Staphylococcal  Cells.- 
One ml. of an overnight culture of S. aureus producing coagulase  II was placed  in 50 ml. 
tryptose broth containing 1 ml. of albumin. Mter incubation for 48 hours at 37°C., the cells 
were sedimented by centrifugation. The supernatant was decanted and buffer was added to 
make a  1:5 dilution of the bacterial cells. To 0.5 ml. of the bacterial suspension was added 
0.5 ml. of monkey serum. A similar amount of buffer was added in a second  tube to 0.5 ml. 
of the same monkey serum. The 2 tubes were placed at 4°C. overnight during which time they 
were agitated occasionally.  Following centrifugation the supernates were removed. The two 
serum specimens were  then inactivated twice at  60°C.  /or  20  minutes and  the  antibody 
content determined by the method described  (4). The results are shown in Table V. 
There  was  only a  slight decrease  in the  antibody to  coagulase  II, whereas 
the antibody to coagulase I  did not change. No further attempts to neutralize 
with organisms were  made. 
Neutralization  with Coated  Collodion  Particles.- 
Collodion particles were prepared by the method of Cavelti (5), but no attempt was made 
to  obtain particles of constant size.  Preliminary experiments showed  that  coagulase  was 304  SPECIFIC COAGULASES OF  STAPHYLOCOCCUS AUREUS 
removed from broth preparations absorbed with collodion particles overnight. In each experi- 
ment particles exposed to coagulase and,  as a  control,  to tryptose  broth were used.  Mter 
inactivation at 60°C.  for 20 minutes on two occasions,  2 equal portions of the serum were 
TABLE V 
Specific Neutralization of Anticoagulase in Sera Containing Antibodies to More Than One Type 
of Coagulase 
Serum  Specific neutralization with 
Monkey  Control broth 
Staphylococcus aureus--CII 
Man 
Man 
Monkey 
Man 
Man 
Man 
Man 
Monkey 
Man 
Control broth collodion 
Coagulase I  collodion 
Control broth collodion 
Coagulase III collodion 
Control broth collodion 
Coagulase III collodion 
Control broth 
Coagulase I 
Control broth 
Coagulase I 
Control broth 
Coagulase I 
Control broth 
Coagulase I 
Control broth 
Coagulase II 
Control broth 
Coagulase III 
Control* 
* See text. 
placed in contact with measured quantities of coagulase-coated particles and control particles, 
respectively, for a period of 1 to 3 hours at 37°C. The particles were then removed by centrif- 
ugation and the procedure repeated. 
The results of 3 neutralization experiments are shown in Table V. 
In one instance there was a definite decrease in the antibody titer to coagulase 
I when the serum was neutralized with collodion particles coated with coagulase RAMMELKAMP, HEZEBICKS, AND  DINGLE  305 
I, whereas there was no change in the coagulase II antibody titer. On neutrali- 
zation with particles coated with  coagulase III, there was  a  decrease in titer 
of the  homologous  antibody and  no  change  in  the  titer  of antibodies of  the 
coagulase I  type. In the third neutralization, coagulase III particles caused a 
decrease in both antibodies of the II and III type, with no change in the co- 
agulase I  antibodies. 
Neutralization  with Cell-Free Coagulase.-- 
The serum to be neutralized with cell-free coagulase was first inactivated in a water bath 
at 60°C. for 20 minutes.  It was then placed at 4°C. for 1 hour and again inactivated at 60°C. 
for 20 minutes:  Following this treatment the serum  was divided into 2 equal samples and 
cell-free coagulase was added to one sample and an equal quantity of broth containing albumin 
was added to the other.  The solutions  were mixed and placed at 4°C. overnight.  Antibody 
titrations were performed on each of the 2 specimens. 
Since it was necessary to determine whether an excess of coagulase was used in the neutral- 
ization experiments, the specimen of serum containing coagulase was also diluted in phosphate 
buffer in a series of tubes and the substrate, containing  fibrinogen, reacting factor, and heparin, 
was added. Mter the addition of the substrate all solutions were placed in a water bath at 
37°C. for 3 hours. The tubes were then examined with a hand lens for evidence of clot forma- 
tion. If there was clot formation in any dilution of the tubes containing the neutralized serum 
and the substrate, the experiment was repeated using smaller amounts of coagulase for neutral- 
ization. 
The results of several such experiments  are recorded in Table V. In these experiments it 
was necessary  to perform several preliminary studies so that the proper proportion of serum 
and coagulase could be determined. 
As  is  evident  from  the  results,  neutralization  with  coagulase  I  caused  a 
definite and marked decrease in the antibody to coagulase I, whereas the anti- 
body  to  coagulase  II  remained  constant,  or  in  one  instance  decreased  one 
dilution increment.  In  the experiment where  the serum  was neutralized with 
coagulase  II  there  was  a  decrease  in  antibodies  to  coagulase  II,  and  a  one 
dilution  drop  in  the  antibody to  coagulase  I.  Absorption of  serum  with  co- 
agulase III resulted in a drop of the antibody titer to both coagulases III and I 
DISCUSSION 
The data presented again confirm the antigenicity of cell-free staphylococcal 
coagulase. In addition, it was found that in one monkey infected with a  culture 
of S. aureus  there was an increase in antibodies to the homologous coagulase 
preparation.  Although  it is possible that  antibody production in  this  animal 
was  due  to preformed  coagulase present  in  the  culture medium,  the amount 
should  have  been  small since  maximum  production  requires  several days  of 
incubation.  Subsequent  studies  have  demonstrated  the  production  of  anti- 
coagulase following induced infections with washed staphylococcal cells (6). 
These  results show  that  there  are at  least  2  separate coagulases produced 
by different strains of S. aureus and explain, in part, the difficulties encountered 
in  the past in  the  immunological study  of plasma or serum  of patients with 
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Sudhues and Schimrigk (7) found that plasma of normal subjects and patients with 
staphylococcal infections showed no differences in susceptibility to staphylocoagulase. 
Likewise  Cruickshank (8) found that the plasmas of 4 patients with staphylococcal 
infections were normally susceptible to clotting with coagulase. Tager (9) has studied 
the resistance of human plasma to cell-free coagulase and has found a large proportion 
to be resistant.  No attempt was made to correlate these findings  with a  previous 
history of a staphylococcal infection. 
Lominski and Roberts (10) tested 348 sera, of which  212 contained an inhibitory 
substance to coagulase.  They found that the incidence  of low titer or non-inhibitory 
sera was higher in the patients with major staphylococcal infections than in healthy 
subjects or patients with diseases not caused by staphylococci.  They suggest that a 
low titer predisposes to staphylococcal infections. This suggestion is difficult to under- 
stand in view of the observation made by the same authors that the inhibitory sub- 
stance may be an antibody. Their results are best explained by the failure to use the 
proper coagulase preparation  so  that  antibody to  the  specific  coagulase  could be 
identified.  Using such techniques in this laboratory, it has been possible to show that 
individuals with staphylococcal infections  do exhibit an inhibitory substance in their 
convalescent sera. Another factor which may have influenced the results obtained by 
Lominski and Roberts (10) is that the technique employed for measuring the inhibitory 
substance in sera did not control the amount of reacting substance.  Since clotting 
results from an interaction of coagulase and  the reacting factor, it is necessary to 
control both factors when measuring anticoagulase. 
The data presented would appear to establish more firmly that the inhibitor 
of coagulase is an antibody. The differences in the titer of coagulase inhibitors 
in human serum depending on  the  type  of  coagulase  used  indicate  that  the 
inhibitor  in  this  instance  is specific. Furthermore,  the  neutralization  experi- 
ments with human and monkey serum which demonstrated the specificity of the 
reaction, would support the thesis that the inhibitor is antibody. 
Although  the  name,  coagulase,  implies  that  the  substance  is  an  active 
clotting enz)nue, there is little evidence to support such a  thesis.  It is known 
that staphylococcal coagtflase requires a second factor found in blood of certain 
species for the  production  of the  active clotting substance.  Smith  and  Hale 
(11)  termed this blood factor, activator. However, as Kaplan and Spink  (12) 
emphasize, coagulase may be the activator. For this reason the term "reacting 
factor" is employed, as first suggested by Tager (13).  Until the mechanism of 
the  reaction  is  further  clarified  it  would  appear  that  antigenically  different 
coagulases have similar properties so far as reacting with a substance in blood 
to produce an active clotting substance. 
The  demonstration  of  serological  differences  in  the  coagulases  suggests 
that strains of S. aureus might be differentiated by this means. At the present 
time the number of staphylococcal coagulases is not known, but it would appear 
that  cross-reactions may preclude the use of coagulases as a  means to differ- 
entiate more than a  few strains.  Thus,  coagulase III appears to be related in RAM~ELKAMP,  HEZEBICKS,  AND  DINGLE  307 
part  to both  coagulases I  and  II.  Preliminary observations employing other 
coagulase  preparations  indicate  that  such  cross-reactions  may be  common. 
It is possible also that mutations occur, so that the coagulase type changes. 
SLrMMARY 
Three  staphylococcal coagulases termed I,  II,  and III were differentiated 
by measuring the antibody titer of human sera. Coagulases I  and II are an- 
tigenically distinct; coagulase III appears  to be related to both coagulases I 
and II. These results were confirmed by specific  neutralization experiments. 
These observations emphasize the importance of employing the correct type 
of  coagulase  in  studying the  role  of  this  substance  in  the  pathogenesis  of 
staphylococcal infections. Preliminary observations in  animals indicate that 
specific  anticoagulase develops following induced infections. The role of this 
antibody in the recovery mechanism remains to be determined. 
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